Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | 53,322 | reported | 13 Jun 2025 | tx 25+334,455−133,529 |
| SERA PROGNOSTICS, INC. | 35,630 | reported | 06 Mar 2023 | tx 7+255,705−2,830 |
| MYRIAD GENETICS INC | 25,282 | reported | 15 Oct 2007 | tx 437+363,998−325,052 |
| OSIRIS THERAPEUTICS, INC. | 21,500 | reported | 12 Feb 2013 | tx 8+26,500 |
| BioCardia, Inc. |
| 15,573 |
| reported |
| 08 Dec 2025 |
| tx 18+559,967−3,594 |
| ACHIEVE LIFE SCIENCES, INC. | 4,400 | reported | 31 May 2022 | tx 7+81,950 |
| Sintx Technologies, Inc. | 4,000 | reported | 23 Feb 2026 | tx 6+11,784−64,556 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | PURCHASE | Sintx Technologies, Inc. | 1,000 | 2.91 USD | |
| 08 Dec 2025 | GRANT_AWARD | BioCardia, Inc. | 12,000 | 0.00 USD | deriv |
| 26 Aug 2025 | PURCHASE | Sintx Technologies, Inc. | 3,000 | 3.59 USD | |
| 13 Jun 2025 | SALE | PUMA BIOTECHNOLOGY, INC. | 22,000 | 3.40 USD | |
| 11 Jun 2025 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 11 Oct 2024 | GRANT_AWARD | BioCardia, Inc. | 829 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 13 Jun 2024 | SALE | PUMA BIOTECHNOLOGY, INC. | 22,000 | 3.34 USD | |
| 18 Oct 2023 | GRANT_AWARD | BioCardia, Inc. | 12,434 | 0.00 USD | deriv |
| 13 Jun 2023 | SALE | PUMA BIOTECHNOLOGY, INC. | 22,000 | 3.45 USD | |
| 13 Jun 2023 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 06 Mar 2023 | GRANT_AWARD | SERA PROGNOSTICS, INC. | 32,800 | 0.00 USD | |
| 06 Mar 2023 | GRANT_AWARD | SERA PROGNOSTICS, INC. | 51,800 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | BioCardia, Inc. | 12,434 | 0.00 USD | deriv |
| 16 Jun 2022 | SALE | PUMA BIOTECHNOLOGY, INC. | 22,858 | 2.64 USD | |
| 14 Jun 2022 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 31 May 2022 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 4,400 | 0.00 USD | deriv |
| 23 Mar 2022 | GRANT_AWARD | SERA PROGNOSTICS, INC. | 168,275 | 0.00 USD | deriv |
| 19 Jul 2021 | CONVERSION | SERA PROGNOSTICS, INC. | 2,455 | — | |
| 19 Jul 2021 | CONVERSION | SERA PROGNOSTICS, INC. | 375 | — | |
| 19 Jul 2021 | CONVERSION | SERA PROGNOSTICS, INC. | 2,455 | 0.00 USD | deriv |
| 19 Jul 2021 | CONVERSION | SERA PROGNOSTICS, INC. | 375 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,858 | 0.00 USD | |
| 15 Jun 2021 | GRANT_AWARD | BioCardia, Inc. | 12,434 | 0.00 USD | deriv |
| 10 Jun 2021 | SALE | PUMA BIOTECHNOLOGY, INC. | 25,248 | 11.36 USD |